WHO ICTRP trial
Study of peripheral blood MRGPRX2 proteins as a biomarker for the diagnosis of…
ChiCTR2400082024 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400082024 |
|---|---|
| Public title | Study of peripheral blood MRGPRX2 proteins as a biomarker for the diagnosis of seasonal allergic rhinitis |
| Scientific title | Study of peripheral blood MRGPRX2 proteins as a biomarker for the diagnosis of seasonal allergic rhinitis |
| Primary sponsor | Yulin Second Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | seasonal allergic rhinitis |
| Interventions | Gold Standard:skin prick test; specific IgE test;Index test:MRGPRX2 |
| Registration date | Mar 19, 2024 |
| Target size | Target condition:1000;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: